ADMA ADMA Biologics Inc

4.53
-0.3  -6%
Previous Close 4.83
Open 4.82
Price To Book 5.66
Market Cap 209971131
Shares 46,351,243
Volume 152,961
Short Ratio
Av. Daily Volume 175,691

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 181170902
  2. 8-K - Current report 181170556
  3. 8-K - Current report 181125406
  4. 8-K - Current report 181117355
  5. 8-K - Current report 181105767

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued July 29 2016. New PDUFA date April 2, 2019.
RI-002
Primary Immune Deficiency Diseases
PDUFA date delayed two months to December 18, 2018.
BIVIGAM
Primary humoral immunodeficiency

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 181170902
  2. 8-K - Current report 181170556
  3. 8-K - Current report 181125406
  4. 8-K - Current report 181117355
  5. 8-K - Current report 181105767
  6. 8-K - Current report 181096076
  7. CT ORDER - Confidential treatment order 181083390
  8. 8-K - Current report 181053904
  9. 8-K - Current report 181053897
  10. 8-K - Current report 181038106